The early management of gestational diabetes is an opportunity to prevent these adverse outcomes. The Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) was influential in providing evidence that treatment of gestational diabetes according to standard care (at that time) reduced the risk of adverse outcomes to that of women without gestational diabetes. The treatment of gestational diabetes has since progressed with changes to criteria and a move towards a more evidence-based approach, including the development of an Australasian clinical practice guideline. Despite this, controversies exist regarding the diagnosis and management of gestational diabetes. An international, multi-centre randomized controlled trial called the Treatment of Booking Gestational Diabetes Mellitus study is currently underway and aims to provide an answer to these controversies.
This work is licensed under a Creative Commons Attribution 4.0 International License.